1. Grosset, J., Boisvert, H., Lagrange, P., Baranton, G.: Mycobactéries. In: Le Minor, L., Véron, M. (ed.): Bactériologie Médicale. Flammarion médecine sciences, Paris, 1982, p. 657–703.
2. Grosset, J., Jarlier, V., Truffot-Pernot, C., Guelpa-Lauras, C. C., Lecoeur, H.: Activité des nouvelles quinolones sur les mycobactéries. In: Pocidalo, F., Vachon, B., Regnier, B. (ed.): Les nouvelles quinolones. Arnette, Paris, 1985, p. 181–189.
3. Fenlon, C. H., Cynamon, M. H.: Comparative in-vitro activities of ciprofloxacin and other 4-quinolones againstMycobacterium tuberculosis andMycobacterium intracellulare. Antimicrobial Agents and Chemotherapy 1986, 29: 386–388.
4. Collins, C. H., Uttley, A. H.: In-vitro susceptibility of mycobacteria to ciprofloxacin. Journal of Antimicrobial Chemotherapy 1985, 16: 575–580.
5. Tsukamura, M.: In-vitro antimycobacterial activity of a new antibacterial substance DL 8280. Differentiation between some species of mycobacteria and related organisms by the DL 8280 susceptibility test. Microbiology and Immunology 1983, 27: 1129–1132.